Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
98 hedge funds and large institutions have $264M invested in Vicarious Surgical in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 14 closing their positions.
1,018% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $171K
214% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 14
40% more funds holding
Funds holding: 70 → 98 (+28)
1% more capital invested
Capital invested by funds: $263M → $264M (+$1.46M)
0.07% more ownership
Funds ownership: 2.63% → 2.7% (+0.07%)
61% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$13.4M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$12.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$9.54M |
| 4 |
6CM
683 Capital Management
New York
|
+$9.43M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$6.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
-$15.8M |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$10.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.24M |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$4.94M |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$4.48M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
101
Tuttle Capital Management
Riverside,
Connecticut
| – | -$1.64M | -5,492 | Closed |
|
|
PCR
102
Potrero Capital Research
San Francisco,
California
| – | -$1.31M | -4,384 | Closed |
|
|
CAC
103
Cowen and Company
New York
| – | -$994K | -3,333 | Closed |
|
|
AA
104
AQR Arbitrage
Greenwich,
Connecticut
| – | -$795K | -2,667 | Closed |
|
105
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$488K | -1,636 | Closed |
|
|
CC
106
Centiva Capital
New York
| – | -$321K | -1,077 | Closed |
|
|
SSA
107
Schonfeld Strategic Advisors
New York
| – | -$178K | -596 | Closed |
|
|
DTL
108
Dynamic Technology Lab
Singapore
| – | -$100K | -335 | Closed |
|
|
SGAM
109
Seaport Global Asset Management
New York
| – | -$12K | -40 | Closed |
|
|
IRC
110
Investors Research Corp
Atlanta,
Georgia
| – | +$298 | +1 | New |
|
|
PA
111
Parallel Advisors
San Francisco,
California
| – | +$298 | +1 | New |
|
|
TWA
112
TCI Wealth Advisors
Tucson,
Arizona
| – | +$298 | +1 | New |
|
RBOT Hedge Fund Activity: Q2 2021 in Review
98 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2021, worth a combined $264M — up 0.55% from $263M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new RBOT positions and 14 closed out — a net gain of 30 holders — while 11 added to existing stakes and 28 trimmed.
The largest buyer was Sculptor Capital, opening a new position worth an estimated $13.4M. The largest seller was RP Investment Advisors, exiting entirely with an estimated $15.8M sold.
- 98 institutional investors held Vicarious Surgical (RBOT) as of Q2 2021, up from 70 in Q1 2021.
- Funds reported $264M of Vicarious Surgical stock for Q2 2021, up 0.55% quarter-over-quarter.
- 44 funds opened new Vicarious Surgical positions in Q2 2021 and 14 closed out, a net change of +30 holders.
- The largest Vicarious Surgical buyer in Q2 2021 was Sculptor Capital, an estimated $13.4M added.
- The largest Vicarious Surgical seller in Q2 2021 was RP Investment Advisors, an estimated $15.8M sold.
Based on aggregated 13F filings for Q2 2021.